Introduction
The overall fertility rate in Europe is declining and has remained below replacement level for years. In 2013 the fertility rate was 1.55 in the European Union countries with the lowest rate (1.22) in Portugal (1). Attempts aimed at increasing birth and fertility rates through restrictions to family planning, including contraception and safe abortions, have repeatedly failed. In Romania restrictive abortion laws did not result in increased birth rates, but resulted in increased maternal mortality and morbidity caused by illegal and unsafe abortions (2) (3) (4) . However, in the majority of European countries easy access to contraception and safe abortion is not considered a threat to fertility rates but instead to be one of the cornerstones of reproductive health care, important for women's health and society (5) .
On a global scale the average contraceptive user rates in Europe are high (6) . There is, however, a large regional variation within Europe (7, 8) . Surveys have shown, for example, that among women aged 15-49 years the use of oral contraceptives ranged from 34% in France (9) to 16% in the Baltic states (7) . Even if contraceptives are available and frequently used, unintended pregnancies still occur. Studies among women seeking abortion have identified inconsistent or incorrect use of contraceptives and/ or recent change to another method as possible causes (10, 11) . Long-acting reversible contraceptive (LARC) have been promoted because they are not user-dependent and therefore minimize the risk of contraceptive failures (12, 13) . However, user rates of LARC are still modest, especially in younger age groups, perhaps through lack of knowledge or incorrect beliefs about these methods and also because of inadequate information from prescribers about LARC methods (14) .
Although there are studies on contraceptive use, fertility, birth, and abortion rates in the Nordic countries (7, 8, (15) (16) (17) (18) (19) there is a lack of research exploring the relation between these four reproductive parameters and differences between countries. The aim of this study was to describe and compare contraceptive use, fertility, birth, and abortion rates in Denmark, Finland, Iceland, Norway, and Sweden. A secondary aim was to explore plausible explanations for the possible differences.
Material and methods
National data on contraception, fertility, birth, and abortion rates were collected from the five Nordic countriesDenmark, Finland, Iceland, Norway, and Sweden -for the period 2008-2013. To further illustrate fertility, birth, and abortion rates in the long-term after the liberalization of abortion legislation in the Nordic countries (1975) , additional data from 1975 to 2007 were also collected. Specific references for these data-sources are given in the Supporting Information (Appendix S1).
Data concerning birth and abortion rates were collected from the National Health Registries and the Tigrab database in Denmark, the National Institute for Health and Welfare in Finland, The Directorate of Health in Iceland, the National Institute of Public Health in Norway, and the National Board of Health and Welfare in Sweden. Birth and abortion rates were according to international praxis defined as per 1000 women aged 15-44 years (20) . Abortion rates according to different age groups were not available from Sweden for 2013.
Total fertility rates for all Nordic countries were collected from Eurostat (1). Total fertility rate was defined as the average number of live births a woman would ever deliver if she were to experience the fertility rate of a given period and survive through her reproductive period of life.
National data on redeemed prescriptions of hormonal contraceptives in the Nordic countries 2008-2013 were collected from the Danish National Prescription Registry, the Finnish Medical Agency, the Icelandic Medicines Agency, the Norwegian Prescription Database, and the Swedish Board of Health and Welfare. Distribution of hormonal methods by age was only available from Denmark, Norway,
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The use of the most effective hormonal contraceptive method, the levonorgestrel-releasing intrauterine system (LNG-IUS), was higher among older compared with younger women, who relied on user-dependent methods. Finland, with the highest user rate of LNG-IUS, had the lowest abortion rate among all women in the Nordic countries.
and Sweden as personal identification data are not recorded for contraceptive sales in Finland and Iceland.
The Nova-T intrauterine device (IUD) dominates among copper intrauterine devices (Cu-IUD) in the Nordic countries and sales figures for the Nova-T IUD were obtained from the main manufacturer (Bayer AG, Berlin, Germany) for all Nordic countries. It was not possible to obtain sales data from other minor suppliers or to group Cu-IUD use according to age. Use of a Cu-IUD was expressed as the percentage of women in the fertile population (15-49 years) using a Cu-IUD.
Contraceptive use is traditionally described among all women aged 15-49 years (6) . To ensure complete contraceptive user data, to achieve internal consistency in the study, and to make comparisons with other studies possible, usage among women below the age of 15 years was included in the 15-to 19-year age group, and usage among women aged >49 years was included in the age group 45-49 years. The collected data provide information on sold packages or items of different types of contraceptives expressed as defined daily doses. Use of combined oral contraceptive, progestogen-only pill (POP), the contraceptive patch, the vaginal ring and depot injection was expressed as defined daily doses/100 women and day.
To be able to compare defined daily doses/100 women and day for Cu-IUDs and the levonorgestrel-releasing intrauterine system (LNG-IUS) with other contraceptive methods, the mean duration of use for Cu-IUDs was set to four years (21) and the two LNG-IUS which were avaiable were set to four years (21) and two years (22) , respectively. Similarly we calculated the equivalent mean duration of use for an etonogestrel implant to be two years according to the average duration of use reported in a previous study (21) . The mean duration of use for levonorgestrel-releasing implants was set to four years.
Use of less reliable contraceptive methods such as fertility awareness methods, condoms, and diaphragms was not estimated. Women who were infertile, not heterosexually active, pregnant, or who wished to get pregnant were included in the study population as all variables were collected on a group level from anonymous data concerning women of reproductive age (15-49 years).
Demographic data were collected from Facts about the Nordic Region (23) and information about policies, guidelines, and legislation concerning contraceptives and abortions was collected from each Nordic country by members of the research group.
Statistical analyses
In these purely descriptive assessments, no confidence limits were calculated for the country-specific rates. This decision was made given the use of a large sample size from national data for each country making even small differences highly significant, and making such calculations redundant.
Ethical approval
The legal aspects of utilization of registry data for study purposes in Denmark and Norway were performed in accordance with national legislation. For Norway, the board of the Norwegian Prescription Database reviewed the protocol and gave permission for use of the data. Studies using anonymous data from nationwide registers are exempted by Norwegian legislation from the need for institutional regulatory board approvals and written informed consent from the patients. The specific permissions from the relevant body in Denmark was achieved from Datatilsynet (journal no. 2010-41-4778). In Finland, Iceland, and Sweden no permission was required because these data are publicly available from the national bodies of these countries. Patients were not directly involved in the study because only aggregated data on a group-level were used. No ethical consent was therefore needed.
Results
The total population of women of reproductive age in the Nordic countries, i.e. all women 15-49 years of age, varied between 5.1 and 5.8 million from 1975 to 2013. Educational level varies to some extent in the Nordic countries with the lowest level in Iceland. Average income is similar in all the Nordic countries with the exception of Norway, which has a higher income rate (23).
Fertility, birth, and abortion rates among women of reproductive age Fertility rates remained stable around 1.8 in all countries except for Iceland where the rate declined from 2.7 to around 1.9. In 2013 the fertility rate was 1.7 in Denmark, 1.8 in Finland and Norway and 1.9 in Sweden and Iceland ( Figure 1a) .
Birth rates displayed similar patterns to the overall fertility rates in all countries, with stable levels around 60/ 1000 women 15-44 years of age. In contrast, in Iceland the birth rate declined from 95 to 65/1000 women with the most marked change during [1975] [1976] [1977] [1978] [1979] [1980] [1981] [1982] [1983] [1984] [1985] . In 2013 the birth rate varied between 55 and 65/1000 women aged 15-44 years with Denmark having the lowest and Iceland the highest birth rate, respectively (Figure 1b) .
During the period 1975-2013 the abortion rate declined in Denmark from 27 to 15/1000 women aged 15-44 years and in Finland from 20 to 10/1000, increased in Iceland from 6 to 15/1000 and remained stable in Sweden 20/1000 and Norway 16/1000. The changes in abortion rates took place mainly between 1975 and 1995, whereas from 1997, a relatively stable pattern was seen in all countries (Figure 1c ).
Contraceptive use among women of reproductive age
The overall use of contraception among women aged 15-49 years during 2008-2013 was higher in Denmark (39-44%), Sweden (40-42%), and Finland (40-41%) compared with Norway (33-34%) and Iceland (31-33%) (Figure 2 ). The levels of hormonal contraceptive use in each country were fairly stable during 2008-2013, with the exception of Denmark where a small increase was noted mainly due to increasing use of the LNG-IUS. In 2013, the estimated use of Cu-IUDs was highest in Sweden (7%), followed by Denmark (3%), Iceland (2%), and Norway and Finland (1%), whereas Finland had the highest use of the LNG-IUS (15%) followed by Sweden and Denmark at 11%, and Norway and Iceland at 8% (Figure 2) .
Hormonal contraceptive use, birth, and abortion rates in different age groups Hormonal contraceptive use, birth, and abortion rates for Denmark, Norway, and Sweden during the period 2008-2013 are stratified according to age in Figure 3(a-f) . 1 9 7 7 1 9 7 9 1 9 8 1 1 9 8 3 1 9 8 5 1 9 8 7 1 9 8 9 1 9 9 1 1 9 9 3 1 9 9 5 1 9 9 7 1 9 9 9 2 0 0 1 . Teenage births declined from 9/1000 to 6/1000 in Norway where also the steepest decline in the annual rate of teenage abortions from 18 to 10/1000 was reported. In 2012, Sweden still had the highest annual rate of teenage abortions (18/1000) (Figure 3a ).
Women 20-24 years old. In this age group the total hormonal contraceptive user rate was 59-61% in Denmark, 53-57% in Norway, and 48-51% in Sweden (Figure 3b) . CHC was still the most commonly used method in this age group in all countries. The use of POP was highest in Sweden compared with Norway and Denmark (Figure 3b ). Birth rates were higher compared with the teenage group although a decline was seen during the study period 2008-2013 in Norway and Denmark. The abortion rate was higher in the age group 20-24 years in all three countries compared with all other age groups (Figure 3a-f ) and the highest rate was seen in Sweden (Figure 3b ).
Women 25-29 years old. Compared with 20-to 24-year-old women the total use of hormonal contraception decreased and birth rates doubled for all three countries in this age category. The total hormonal contraceptive user rate varied between 45-47% in Denmark, 38-42% in Norway, and 35-37% in Sweden. CHC use was still high, but there was an increasing use of LNG-IUS. More POP were used in Norway and Sweden than in Denmark. (Figure 3c ). Birth rates were higher whereas the abortion rates were lower compared with 20-to 24-year-old in all countries (Figure 3b,c) .
Women 30-34 years old. Total hormonal contraceptive use decreased further and CHC use gave way to LNG-IUS and POP use (Figure 3d ). The birth rates peaked in this age group in all countries with the highest levels in Norway.
Women 35-39 and 40-44 years old. In these age groups the use of CHC decreased gradually whereas the use of LNG-IUS increased to become the dominant contraceptive method. This changing scenario was seen later in Denmark than in Norway and Sweden. There was a more marked increase in use of the LNG-IUS in Denmark (Figure 3d-f) . In all three countries, birth and abortion rates gradually declined for every age group from 35 to 44 years. Sweden had the highest rate of both births and abortions in these age groups (Figure 3e,f) .
Possible factors influencing contraception and abortion
Some degree of financial assistance regarding the cost of contraception is provided in Finland (depending on the community), Norway, and Sweden. Denmark and Iceland have no subvention at all. There were some differences between the countries regarding availability of clinical guidelines. Also, abortion legislation differed between the countries where Finland and Iceland require an approval from one or two doctors, or from a national authority depending on the indication or gestational age (Table 1) .
Discussion
Fertility and birth rates in the Nordic countries have remained stable with the exception of Iceland. This is in contrast with the rest of Europe where declining rates have frequently been reported (1). The total abortion rate has been largely unchanged in all countries after 1997. Also, the overall use of contraception has remained relatively stable in recent years. In the European context the Nordic countries are among the countries with the highest user rates of hormonal methods and Cu-IUDs.
The main strength of this study was the use of national register data that included all women of reproductive age in the Nordic countries. These registries are considered highly reliable even though redeemed prescriptions do not necessarily mean that the contraceptives have actually been used. However, according to Triebwasser et al., pharmacy claims are more reliable than self-reported use, as women tend to overestimate their contraceptive use when selfreported (24) . A limitation in this study was the lack of agespecific data on Cu-IUDs for all countries and age-specific contraceptive use for Finland and Iceland. Since Finland has the lowest abortion rate it would have been of interest to compare age-specific contraceptive use and abortion data, especially for the youngest and most fertile subgroups. Another limitation was the lack of data on other contraceptive methods in the Nordic national registers.
It has been suggested that the government's support for combining family with a working career is the key to keeping a high birth rate (5, 25) . The Nordic countries offer parental leave for both women and men and accessible and affordable child care, which may contribute to a positive attitude towards combining a working career with having a family and hence higher birth rates. France is another example of how a strong support for combining work and family life may help to keep birth rates close to the replacement level. The Nordic countries and France have shown that it is possible to combine high birth rates with good access to family planning methods including safe abortion on women's request (5, 25) . Total abortion rates in all the Nordic countries are lower than the overall rate in the developed world (24/ 1000 women and year in 2008) (26) . Countries in western and southern Europe, with comparable abortion legislation and contraceptive availability as in northern Europe, have abortion rates of 12 and 18/1000, respectively, which is similar to what we found in the Nordic countries (26) .
There was no clear correlation between the contraceptive user rates and abortion rates. However, in the highly fertile and sexually active age group of 20-to 24-year-old women, Sweden had the highest abortion rate and a lower contraceptive user rate than Denmark and Norway. A similar, but less pronounced pattern was also seen among the 25-to 29-yearold women. Another finding was that the user rate of one of the most effective hormonal contraceptive methods, the LNG-IUS, was higher among older women than among younger women, who instead relied on user-dependent methods. It is also noteworthy that Finland had the highest user rate of LNG-IUS among all women of reproductive age and the lowest abortion rate among the Nordic countries.
Sweden had a higher rate of Cu-IUD use. However, it is unlikely that this could compensate for the lower user rates of hormonal contraceptives among the younger women, as it has been shown that the user rates of Cu-IUDs continue to be low in the younger age groups in Sweden (27, 28) . Sweden also had a higher user rate of POP in all age groups. The continuation rate for POP is lower than for other oral methods (29) and may influence the number of unintended pregnancies.
Differences in abortion rates may also be due to differences in access to abortion care and unmet/met needs of abortions. The abortion legislation and services in the Nordic countries vary to some extent. In Finland and Iceland, approval from one or two physicians is required for an abortion in early pregnancy and this might constitute a barrier for seeking abortion care. Nevertheless, interpretation of the legislation is liberal and women have ready access to abortion in early gestation (National institute for Health and Welfare, Finland; see Supporting Information, Appendix S1). It might be tempting to argue that Finland's abortion law is in part a reason for its lower abortion rate, but Finland had the same abortion legislation in the mid1970s, when Finland had the same abortion rate as Sweden. Iceland was the only Nordic country where the abortion rate increased during the period 1975-2013. The reasons for this are probably multifactorial but the Icelandic authorities have not been able to make available specialized contraceptive clinics in their sparsely populated, widespread country. In fact, at the time of this study there was only one youth clinic in Iceland.
In the present study, there was no association between subsidy systems and abortion rates, which has sometimes been suggested to lead to lower abortion rates (30) .
In contrast to the lower average fertility and birth rates in Europe, rates in the Nordic countries remain high and stable despite liberal access to abortion on women's request and high contraceptive use. Nevertheless, use of highly effective LARC was still low in the younger age groups during the study period. Interventions that increase the number of women who use highly effective contraceptives, improve the compliance of contraceptive use, and increase the possibility to reach out to vulnerable groups, should all be considered to further reduce the rate of unwanted pregnancy. 
